FDA recall D-106-2013
Hospira Inc. · Class II · drug
Product
Epinephrine Injection USP, 1 mL, USP 1:1000 (1 mg/mL), SQ/IM, Hospira, Inc., Lake Forest, IL --- NDC 0409-7241-01
Reason for recall
Presence of Particulates; may contain glass particles
Distribution
Nationwide
Key facts
- Status
- Terminated
- Initiation date
- 2012-10-25
- Report date
- 2013-01-09
- Termination date
- 2014-10-15
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Lake Forest, IL, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-106-2013